NCT05957549

Brief Summary

Individuals with Fragile X Syndrome show differences in how they understand and learn language from infancy. They frequently have lifelong delays in speech and language as well. In addition, they experience other auditory symptoms, including being very sensitive to certain sounds as well as being more sensitive than others to loud sounds. The underlying brain activity for sound perception and speech learning in Fragile X is not well understood, especially in the infant, toddler, and preschool years. This study uses behavioral assessment of speech and language abilities, neuroimaging, and hearing tests to understand how speech and hearing are different in children with Fragile X Syndrome.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
10mo left

Started Oct 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress82%
Oct 2022Mar 2027

Study Start

First participant enrolled

October 4, 2022

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

July 3, 2023

Completed
21 days until next milestone

First Posted

Study publicly available on registry

July 24, 2023

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2027

Last Updated

July 10, 2025

Status Verified

July 1, 2025

Enrollment Period

4.4 years

First QC Date

July 3, 2023

Last Update Submit

July 6, 2025

Conditions

Outcome Measures

Primary Outcomes (6)

  • Change in Mullen Scales of Early Learning

    change in Mullen Scales scores (age-corrected) from baseline on all subscales, including Expressive Language, Receptive Language, FIne Motor, Gross Motor, and Visual Reception. T-Scores from the Mullen Scales of Early Learning (MSEL) have a mean of 50 and a standard deviation of 10. Range=20-80. Higher scores indicate more advanced developmental skills.

    at single study visit between ages of 2-4 years inclusive

  • Changes in oxygenated and deoxygenated hemoglobin concentration in response to sounds in language regions of the brain

    Relative increase in oxygenated versus deoxygenated hemoglobin for no sounds, low intensity sounds, and medium intensity sounds. Measured via functional Near Infrared Spectroscopy with optodes placed over frontal, temporal, and parietal language regions.

    at single study visit between ages of 2-4 years inclusive

  • Changes in amplitude of mismatch negativity response during sound discrimination

    Electroencephalography is measured over the scalp while participant listens to speech sounds with infrequent "oddball" stimuli. Amplitude of the P100 for all stimuli as well as amplitude of the mismatch negativity response (frequent minus infrequent response) as well as change in these metrics over development are tracked in all groups.

    at single study visit between ages of 2-4 years inclusive

  • Changes in hearing thresholds

    Hearing thresholds in dB as assessed using Conditioned Play Audiometry (CPA) or Visual Reinforced Audiometry (VRA) dependent on child age and developmental ability.

    at single study visit between ages of 2-4 years inclusive

  • Otoacoustic Emissions (OAEs)

    Signals produced by excitation of hair cells in cochlea are measured for a range of frequencies.

    at single study visit between ages of 2-4 years inclusive

  • Changes in tympanometric pressure profile in the inner ear

    Wide Band Tympanometry is completed to measure variability in tympanometric pressure for left and right ears that may affect hearing profile.

    at single study visit between ages of 2-4 years inclusive

Secondary Outcomes (2)

  • Sensory profile 2 Auditory Processing subtest

    at single study visit between ages of 2-4 years inclusive

  • Sensory Profile 2 Attentional subtest

    at single study visit between ages of 2-4 years inclusive

Study Arms (1)

Speech Sounds

EXPERIMENTAL

Participants listen to speech sounds while the investigators measure electrical and hemodynamic changes in the brain.

Other: Speech discrimination

Interventions

Two different speech sounds are played at the same sound intensity.

Speech Sounds

Eligibility Criteria

Age24 Months - 4 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Diagnoses of Fragile X Syndrome, Typical Development, or History of Premature Birth
  • able to sit independently
  • English is spoken at home

You may not qualify if:

  • For all participants: no seizures in the past 6 months
  • For typical development group and Fragile X group: not born prior to 32 weeks gestation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cincinnati Children'S Hospital

Cincinnati, Ohio, 45229, United States

RECRUITING

MeSH Terms

Conditions

Fragile X Syndrome

Interventions

Speech Perception

Condition Hierarchy (Ancestors)

X-Linked Intellectual DisabilityIntellectual DisabilityNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSex Chromosome DisordersChromosome DisordersCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesGenetic Diseases, InbornGenetic Diseases, X-LinkedHeredodegenerative Disorders, Nervous System

Intervention Hierarchy (Ancestors)

Auditory PerceptionVestibulocochlear Physiological PhenomenaPhysiological Phenomena

Central Study Contacts

Elizabeth Smith, PhD

CONTACT

Craig Erickson, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 3, 2023

First Posted

July 24, 2023

Study Start

October 4, 2022

Primary Completion (Estimated)

March 1, 2027

Study Completion (Estimated)

March 1, 2027

Last Updated

July 10, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will share

Deidentified information will be shared as required for NIH grant supported studies.

Shared Documents
STUDY PROTOCOL

Locations